Literature DB >> 23098523

Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis.

Xiang-Ju Long1, Shan Lin, Ya-Nan Sun, Zhen-Feng Zheng.   

Abstract

BACKGROUND/AIMS: Diabetes mellitus (DM) is widely considered to be associated with risk of cancer, but studies investigating the association between DM and prostate cancer in Asian countries have reported inconsistent findings. We examined this association by conducting a detailed meta-analysis of studies published on the subject.
METHODS: Cohort or case-control studies were identified by searching Pubmed, Embase and Wanfang databases through May 30, 2012. Pooled relative risk (RR) with its corresponding 95% confidence interval (95% CI) were calculated using the random-effects model. Subgroup analyses were performed by the study type.
RESULTS: Finally, we identified 7 studies (four cohort studies and three case-control studies) with a total of 1,751,274 subjects from Asians. DM was associated with an increased risk of prostate cancer in Asians (unadjusted RR= 2.82, 95% CI 1.73-4.58, P < 0.001; adjusted RR= 1.31, 95% CI 1.12-1.54, P = 0.001). Subgroup analyses by study design further confirmed an obvious association.
CONCLUSION: Findings from this meta-analysis strongly support that diabetes is associated with an increased risk of prostate cancer in Asians.

Entities:  

Mesh:

Year:  2012        PMID: 23098523     DOI: 10.7314/apjcp.2012.13.8.4097

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  14 in total

1.  Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium.

Authors:  Yu Chen; Fen Wu; Eiko Saito; Yingsong Lin; Minkyo Song; Hung N Luu; Prakash C Gupta; Norie Sawada; Akiko Tamakoshi; Xiao-Ou Shu; Woon-Puay Koh; Yong-Bing Xiang; Yasutake Tomata; Kemmyo Sugiyama; Sue K Park; Keitaro Matsuo; Chisato Nagata; Yumi Sugawara; You-Lin Qiao; San-Lin You; Renwei Wang; Myung-Hee Shin; Wen-Harn Pan; Mangesh S Pednekar; Shoichiro Tsugane; Hui Cai; Jian-Min Yuan; Yu-Tang Gao; Ichiro Tsuji; Seiki Kanemura; Hidemi Ito; Keiko Wada; Yoon-Ok Ahn; Keun-Young Yoo; Habibul Ahsan; Kee Seng Chia; Paolo Boffetta; Wei Zheng; Manami Inoue; Daehee Kang; John D Potter
Journal:  Diabetologia       Date:  2017-03-07       Impact factor: 10.122

2.  Prostate cancer risk in pre-diabetic men: a matched cohort study.

Authors:  Adedayo A Onitilo; Richard L Berg; Jessica M Engel; Rachel V Stankowski; Ingrid Glurich; Gail M Williams; Suhail A R Doi
Journal:  Clin Med Res       Date:  2013-05-08

3.  Prospective study of cancer in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.

Authors:  Masanori Iwase; Hiroki Fujii; Yasuhiro Idewaki; Udai Nakamura; Toshiaki Ohkuma; Hitoshi Ide; Yuji Komorita; Tamaki Jodai-Kitamura; Masahito Yoshinari; Takanari Kitazono
Journal:  Diabetol Int       Date:  2019-02-20

4.  Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis.

Authors:  Jong-Myon Bae
Journal:  Epidemiol Health       Date:  2015-02-11

5.  The Impact of Diabetes on the Risk of Prostate Cancer Development according to Body Mass Index: A 10-year Nationwide Cohort Study.

Authors:  Jin Bong Choi; Hyong Woo Moon; Young Hyun Park; Woong Jin Bae; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Sae Woong Kim; Kyung-Do Han; U-Syn Ha
Journal:  J Cancer       Date:  2016-10-22       Impact factor: 4.207

6.  Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.

Authors:  Kerri Beckmann; Danielle Crawley; Tobias Nordström; Markus Aly; Henrik Olsson; Anna Lantz; Noor Binti Abd Jalal; Hans Garmo; Jan Adolfsson; Martin Eklund; Mieke Van Hemelrijck
Journal:  JAMA Netw Open       Date:  2019-11-01

7.  Cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai.

Authors:  Hui-Lin Xu; Hong Fang; Wang-Hong Xu; Guo-You Qin; Yu-Jie Yan; Bao-Dong Yao; Nai-Qing Zhao; Yi-Nan Liu; Fen Zhang; Wei-Xi Li; Na Wang; Jie Zhou; Jin-Ling Zhang; Li-Yun Zhao; Lun-Qiang Li; Yan-Ping Zhao
Journal:  BMC Cancer       Date:  2015-11-05       Impact factor: 4.430

8.  Impact of metformin on serum prostate-specific antigen levels: Data from the national health and nutrition examination survey 2007 to 2008.

Authors:  Jee Soo Park; Kwang Suk Lee; Won Sik Ham; Byung Ha Chung; Kyo Chul Koo
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.

Authors:  Chin-Hsiao Tseng
Journal:  Oncotarget       Date:  2017-03-21

Review 10.  Metformin and blood cancers.

Authors:  Ademar Dantas Cunha Júnior; Fernando Vieira Pericole; Jose Barreto Campello Carvalheira
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.